Paying Research Participants
*
Paying Research Participants *
A graduate paper on whether the money offered to research participants should be seen as a benefit when review boards evaluate a study’s risk.
Three tensions that follow me from research ethics into patient advocacy
My main concern is to ensure the individual clearly understands what they're agreeing to and why.
Usually, Vulnerable populations enroll in paid studies.
People in risky studies typically do so due to their housing, income, and power situations, not because of personal preference.
What about putting rules in place? Some may say protection can turn into control
Rules designed to protect can also restrict choices, and those who create them often see this as care.
we have to ask more questions.
The Big question: When a review board decides whether a study's risks are acceptable, should the money paid to participants count as a benefit?
-
This is the standard view. Payment is excluded here. Typically, payment is seen as compensation for time and inconvenience, but it should never be used as a reason to accept greater risk.
-
This is the incorporation view: it sees offering payments as a benefit to participants, helping them weigh the benefit against potential risks.
-
Fairness should be recognized once concerns are resolved. Respect means understanding reasoning; justice means reasoning is valid.
Difference between the standard view, and incorporation view
-
Payment is simply a way to compensate someone for their time and effort, with no additional significance. No amount of money can justify a risky study or allow financial incentives to sway the decision.
-
The participant receives the money, so it’s treated like any other benefit. When someone considers the payment worth risking, it’s seen as a decision rather than a mistake.
Financial stability is important, so research that appeals to informed adults with valid reasons to participate isn’t rejected solely due to compensation.
Both sides are quoting the same three principles back at each other
Leaving payment out does not protect a person's autonomy. It overrides it.
*
Leaving payment out does not protect a person's autonomy. It overrides it. *
A decision made during financial hardship can still be truly autonomous if the person understands it and is not pressured. Hardship relates to circumstances, not mental ability. Many believe that people can’t properly compare the risks and benefits of money, judging their competence without questioning. They also unfairly compare all volunteers to an ideal, cautious person who does not exist, ignoring research that shows informed adults often have valid reasons for their choices. For someone struggling to pay rent or buy food, earning extra money is essential. True autonomy is about choosing the benefits that matter most.
Respecting a person means taking their reasoning seriously
A board can't help but wonder if a payment is too tempting to turn down. As soon as that question arises, it's already considering the money. The right thing is to admit it openly.
Consider 10,000 is offered to a healthy volunteer in a phase 1 trial that promises them no medical benefit at all.
This is the first human trial where a healthy volunteer faces risks that haven't been measured yet, and the compound could be toxic. There’s no direct therapeutic benefit; the volunteer is fully aware of the potential reward. Conventionally, the board disregards the volunteer’s personal judgment and examines whether the risk is acceptable in isolation. By then, the decision is often viewed as settled, leaving the volunteer's own perspective unrecorded.•There is no therapeutic benefit on offer here. The payment is the benefit, and the volunteer knows exactly that.
What i care for most: Justice, and the making of a research underclass
Recruitment keeps returning to the same people
Voluntary and free are not the same thing
Exploitation is a question about who carries the burden
We need to:
Start with consent
The board must ensure that the individual was given enough information to genuinely grasp the study, and that no one involved pressured them into agreeing.
Then look at who is being asked
Recruitment should be rooted in fairness, not merely in selecting individuals who are easiest to access because of financial difficulties. Fairness is a fundamental principle that guides us toward ethical and just choices.
ONLY THEN, we can count payment.
Payment can be a way to acknowledge that a person considers the risks involved and agrees to them, based on their own reason and judgment. It can also be openly recorded along with the risks and benefits, so nothing is hidden. Additionally, payment can meet a real need in someone's life, rather than indicating a lack of clear thinking. However, paying someone cannot make a study with very high risks acceptable. It also cannot replace ethical recruitment or honest conversations about what the study involves. Nor should payment be so large that it skews a person's view of the risks. True understanding depends on more than just money.
In risky research experiments, there is a consistent dilemma about whether we should pay research participants. The ethical debate surrounding research participation focuses on the tension created by offering financial payments to subjects (Wertheimer, 2011, pp. 119–142), particularly when those funds may act as an "undue inducement" for economically disadvantaged persons to accept high risks against their "better judgment" (Elliott & Abadie, 2008, p. 2317). This practice risks exploiting a vulnerable "research underclass" (Elliott & Abadie, 2008, p. 2316) but may, on the other hand, undermine their autonomy. The fundamental question is: Should Institutional Review Boards (IRBs) incorporate payment into the formal risk-benefit analysis, or exclude it to avoid undue inducement strictly?
Respect for persons requires IRBs to adopt the incorporation view when payment genuinely reflects autonomous valuation of risk, but this must be constrained by justice principles to prevent exploitation. To defend this position, I begin by explaining the theoretical framework and contrasting the currently favored standard view (which holds that IRBs must exclude payments when assessing risks) with the incorporation view (which treats payments as benefits offsetting risk) (Wertheimer, 2011, pp. 483–486). I will defend the incorporation view based on the inherent requirement to respect participant autonomy, consider the powerful objection stemming from the principle of justice (specifically, the risk of structural exploitation), and conclude with a qualified reconciliation that balances validating individual consent with rigorous societal safeguards in the name of justice.
The standard view (or exclusion view), which represents the virtually universal regulatory approach, maintains that IRBs must completely ignore the value of financial payments when assessing whether research risks are reasonable in relation to anticipated benefits (Wertheimer, 2011, pp. 125, 485). The payment is strictly categorized as compensation for time and inconvenience, not a benefit that can ethically justify the study's risk (Wertheimer, 2011, p. 126). The rationale is to prevent "undue inducement," ensuring that risks that are otherwise unacceptable cannot be made acceptable simply by offering increasing sums of money. This constraint seeks to preserve the impartiality of risk evaluation (Wertheimer, 2011, pp. 485–490).
Conversely, the Incorporation View argues that the IRB should consider financial payment as a benefit to participants when conducting the risk/benefit calculus. Advocates contend that respecting the participant's autonomy requires respecting a person's reasonable judgment that a substantial payment offsets the risks of participation (Wertheimer, 2011, pp. 478–489).
This controversy engages core ethical principles. Respect for Persons mandates that participation be voluntary and free from undue influence (coercion by excessive reward)(The Belmont Report, 1979, p. 5). Justice and Fair Subject Selection require that vulnerable populations, such as the economically disadvantaged, are not systematically targeted for burdensome risks (The Belmont Report, 1979, p. 411), thereby avoiding exploitation. Finally, Beneficence requires minimizing harms and ensuring risks are reasonable in relation to anticipated benefits (The Belmont Report, 1979, p. 390). The ethical question, then, is whether excluding payment protects or undermines autonomy when participants' consent is fully informed.
The core argument for adopting the Incorporation View rests on the ethical mandate of Respect for Persons. I will begin this argument by explaining that respect for persons entails honoring autonomous, informed decisions, even when made under economic constraints, treating individuals as autonomous agents capable of deliberation about personal goals and choices. It is critical to recognize that a decision remains autonomous, even if the agent is in a desperate situation arising from injustice, provided the decision itself was not distorted and voluntary. (Wertheimer, 2011, pp. 147, 536). If a participant's consent is informed and the decision is voluntary and uncoerced, the ethical framework requires giving weight to their considered opinions and choices (The Belmont Report, 1979, p. 396).
The Standard View mandates that Institutional Review Boards ignore financial payments entirely when determining whether risks are reasonable (Wertheimer, 2011, pp. 125, 460). This view is criticized because it assumes individuals cannot rationally weigh money against risk, thereby implying paternalism (Wertheimer, 2011, p. 466). This approach relies on a "moderate altruist" or "prudent subject criterion", effectively denying an individual the freedom to act on their own considered judgment (Wertheimer, 2011, p. 466). This constraint is paternalistic because it assumes that the IRB knows the participants' best interests better than the participants themselves. The Standard View thereby risks rejecting studies that autonomous, rational individuals want to participate in (Wertheimer, 2011, p. 475). For example, when a healthy participant volunteers for a Phase 1 drug trial, which inherently exposes them to unknown risks, as the drug may be poisonous, (McNeill, 1997, p. 392), in exchange for a large payment of $10,000, the IRB, operating under the Standard View, refuses to validate the participants' judgement that the money offsets the risk.
Nevertheless, autonomy includes subjective valuations of what counts as benefit, such as financial stability (Wertheimer, 2011, p. 517). The principle of independence demands that we must evaluate the reasonableness of a person's participation in light of their own circumstances and values. Economically disadvantaged individuals may rationally regard financial gain as a benefit that outweighs the burdens of research. For a person struggling to secure basic needs like food and shelter, money is not merely an "extraneous benefit" (Emanuel, Wendler & Grady, 2000, p. 2705) but can satisfy fundamental interests (Wertheimer, 2011, p. 594). In this way, the inclusion of payment respects the agent's capacity to determine what constitutes benefit in their own lives. This approach prevents the suboptimal state of affairs in which IRBs block research that would benefit society and participants due to an arbitrarily constrained definition of benefit (Wertheimer, 2011, pp. 475–476).
Therefore, IRBs should include the payment in risk-benefit analysis when consent is informed and comprehension is verified (Wertheimer, 2011, p. 486). Because IRBs are ethically required to ensure that financial payments do not constitute an undue inducement, they cannot avoid assessing whether participants' decisions to accept the trade-off are reasonable in light of the payment. (Wertheimer, 2011, p. 532). Consequently, if it is reasonable for the subject to regard the payment as an offset for the risk, the IRB has a prima facie reason to respect their judgment and incorporate that judgment into the formal risk/benefit assessment (Wertheimer, 2011, p. 485).
Before addressing the objections, I will defend the position that incorporating payment does not necessarily constitute undue inducement, as inducement is "undue" only if it leads to an irrational or distorted decision.
The primary objection to the Incorporation View, which counts payment as a benefit, is that while it upholds individual Respect for Persons, it drastically undermines the principle of Justice (The Belmont Report, 1979, p. 3; Emanuel, Wendler & Grady, 2000, p. 2707). Critics argue that systemically funding high-risk, "no expected benefit" studies, such as Phase 1 drug trials, with large payments creates profound distributive inequalities. This practice tends to recruit vulnerable groups, like the homeless population, who form a "research underclass" (Elliott & Abadie, 2028, p. 2316). The principle of Fair Subject Selection requires that vulnerable groups are not systematically targeted due to their easy availability, compromised position, or manipulability (The Belmont Report, 1979, p. 4) When the burdens of risky research fall disproportionately on the disadvantaged it risks exploitation, which occurs when a person receives an unfair burden of risks (Emanuel, Wendler, & Grady, 2000, p. 2707). Even if consent is formally voluntary, economic desperation may lead people with low incomes to enroll under compulsion, making the consent "voluntary but not free" in a substantive sense (Wertheimer, 2011, p. 147). This demographic disproportionately violates justice because groups who assume the risks and burdens of research should be in a position to enjoy the benefits (The Belmont Report, 1979, p. 4; Elliott & Abadie, 2008, p. 2317).
Emanuel, Wendler, and Grady (2000) emphasize that minimizing the risk of exploitation is critical, defining it as the imposition of an unfair burden of risk (p. 2707). They and others argue that autonomy cannot justify exploitation if participants' choices reflect a systemic inequality rather than a genuine free preference. Therefore, IRBs should cautiously include payment in ethical risk assessment, respecting participants' autonomy without perpetuating structural inequality. Payments should not blind subjects to potential risks or impair their ability to exercise proper judgment (undue inducement) (McNeill, 1997, p. 393; Wertheimer, 2011, p. 153).
Having addressed the justice-based objection, I conclude by considering what these arguments reveal about the balancing of autonomy and fairness in research ethics.
The reconciliation requires integrating the competing demands of autonomy and justice into a policy of contextual incorporation. The refined stance is that Respect for Persons justifies the inclusion of financial payment as a legitimate benefit only after Justice safeguards are satisfied (Wertheimer, 2011, pp. 125–129, 536). Monetary incentives cannot ethically justify risks that are otherwise unacceptable. (Emanuel, Wendler, & Grady, 2000, p. 2704).
Taking a hybrid model resolves the dilemma. The researcher must guarantee that the participant provides informed consent and has a sufficient understanding of the study's risks (Bromwich & Millum, 2013, pp. 10–20). Valid consent is based on disclosure designed to prevent researchers from exercising illegitimate control over the enrollment decision. Further, IRBs must confirm that the research adheres to Fair Subject Selection principles, ensuring that economically disadvantaged populations are not systematically targeted solely because of their easy availability (The Belmont Report, 1979, p. 4). Finally, payments must be monitored so they do not constitute an undue inducement that causes subjects to make an irrational decision about the risks. (Wertheimer, 2011, pp. 153–580).
This approach resolves an exclusionary payment system that leads to paternalism, denying rational agents the opportunity, yet allowing payments without prior justice constraints risks structural exploitation, unfairly shifting research burdens to people experiencing poverty. With this model, the goal is to maximize autonomy while minimizing distributive injustice. (Emanuel, Wendler & Grady, 2000, p. 2707).
Respect for Persons fundamentally requires IRBs to adopt a contextual Incorporation View, counting financial payment as a legitimate risk-offsetting benefit when autonomously valued, provided this practice is strictly constrained by the principle of justice to prevent structural exploitation. (Wertheimer, 2011, p. 489; Emanuel, Wendler & Grady, 2000, p. 2707).
IRBs should implement a hybrid policy that does not permit payment to justify risks that are widely unacceptable. This approach permits IRBs to cautiously include payment in ethical risk assessment, respecting participants' rational economic self-assessment (Wertheimer, 2011, p. 488) without allowing the incentive to become an undue inducement that causes an irrational decision. This requires adherence to Fair Subject Selection to prevent disproportionate targeting of economically or educationally disadvantaged persons (The Belmont Report, 1979, p. 4). The broader task of research ethics is to balance liberty and protection, ensuring that justice tempers, but never erases, autonomous choice (Wertheimer, 2011, pp. 141–483).